Fort Sheridan Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,478
| Closed | -$206K | – | 239 |
|
|
2024
Q1 | $206K | Sell |
7,478
-199
| -3% | -$5.47K | 0.04% | 194 |
|
|
2023
Q4 | $234K | Buy |
7,677
+357
| +5% | +$10.9K | 0.05% | 173 |
|
|
2023
Q3 | $231K | Hold |
7,320
| – | – | 0.05% | 167 |
|
|
2023
Q2 | $299K | Hold |
7,320
| – | – | 0.07% | 151 |
|
|
2023
Q1 | $273K | Buy |
7,320
+400
| +6% | +$14.9K | 0.07% | 159 |
|
|
2022
Q4 | $241K | Hold |
6,920
| – | – | 0.08% | 155 |
|
|
2022
Q3 | $387K | Hold |
6,920
| – | – | 0.13% | 115 |
|
|
2022
Q2 | $358K | Buy |
6,920
+1,260
| +22% | +$65.2K | 0.12% | 120 |
|
|
2022
Q1 | $411K | Hold |
5,660
| – | – | 0.12% | 112 |
|
|
2021
Q4 | $669K | Hold |
5,660
| – | – | 0.19% | 87 |
|
|
2021
Q3 | $759K | Hold |
5,660
| – | – | 0.25% | 74 |
|
|
2021
Q2 | $916K | Hold |
5,660
| – | – | 0.31% | 57 |
|
|
2021
Q1 | $454K | Buy |
5,660
+59
| +1% | +$4.73K | 0.18% | 84 |
|
|
2020
Q4 | $305K | Buy |
+5,601
| New | +$305K | 0.15% | 92 |
|